Codexis to Participate in Upcoming Healthcare Conferences
Codexis (NASDAQ: CDXS), a leading enzyme engineering company, has announced its participation in two upcoming healthcare conferences. Management will engage in fireside chats at:
1. The Cantor Global Healthcare Conference in New York on September 17, 2024, at 11:30 am ET.
2. The Craig-Hallum Bioprocessing Conference (Virtual) on September 19, 2024, at 2:00 pm ET.
A live webcast of the Cantor fireside chat will be available on the company's Investor Relations website. A replay of the Craig-Hallum fireside chat will be accessible within 48 hours of the presentation. Both replays will be archived for at least 90 days following the presentation date.
Codexis (NASDAQ: CDXS), un'azienda leader nell'ingegneria enzimatica, ha annunciato la sua partecipazione a due prossimi convegni nel settore sanitario. La direzione parteciperà a conversazioni informali presso:
1. La Cantor Global Healthcare Conference a New York il 17 settembre 2024, alle 11:30 ora ET.
2. La Craig-Hallum Bioprocessing Conference (Virtuale) il 19 settembre 2024, alle 14:00 ora ET.
Una diretta streaming della conversazione alla Cantor sarà disponibile sul sito web delle Relazioni con gli Investitori della compagnia. Una registrazione della conversazione alla Craig-Hallum sarà accessibile entro 48 ore dalla presentazione. Entrambe le registrazioni saranno archiviate per almeno 90 giorni dopo la data della presentazione.
Codexis (NASDAQ: CDXS), una empresa líder en ingeniería enzimática, ha anunciado su participación en dos próximas conferencias de salud. La dirección participará en charlas informales en:
1. La Cantor Global Healthcare Conference en Nueva York el 17 de septiembre de 2024, a las 11:30 am ET.
2. La Craig-Hallum Bioprocessing Conference (Virtual) el 19 de septiembre de 2024, a las 2:00 pm ET.
Una transmisión en vivo de la charla de Cantor estará disponible en el sitio web de Relaciones con Inversores de la empresa. Una repetición de la charla de Craig-Hallum estará accesible dentro de 48 horas posteriores a la presentación. Ambas repeticiones se archivarão por al menos 90 días después de la fecha de presentación.
코덱시스 (NASDAQ: CDXS)는 효소 엔지니어링의 선두 기업으로서 두 개의 다가오는 의료 회의에 참여할 것이라고 발표했습니다. 경영진은 다음과 같은 비공식 대화에 참여할 예정입니다:
1. 2024년 9월 17일 오전 11시 30분 ET에 뉴욕에서 열리는 칸토 글로벌 건강 회의.
2. 2024년 9월 19일 오후 2시 ET에 열리는 크레이그-할럼 생물처리 회의 (가상).
칸토의 대화는 회사의 투자자 관계 웹사이트에서 실시간 웹캐스트로 제공될 것입니다. 크레이그-할럼의 대화 기록은 발표 후 48시간 이내에 접근할 수 있습니다. 두 번의 기록 모두 발표 날짜 이후 최소 90일 동안 보관됩니다.
Codexis (NASDAQ: CDXS), une entreprise leader dans le domaine de l'ingénierie enzymatique, a annoncé sa participation à deux prochaines conférences dans le secteur de la santé. La direction participera à des discussions informelles lors de :
1. La Cantor Global Healthcare Conference à New York le 17 septembre 2024 à 11h30 ET.
2. La Craig-Hallum Bioprocessing Conference (virtuelle) le 19 septembre 2024 à 14h00 ET.
Une diffusion en direct de la discussion de Cantor sera disponible sur le site Web des Relations avec les Investisseurs de l'entreprise. Une rediffusion de la discussion de Craig-Hallum sera accessible dans les 48 heures suivant la présentation. Les deux rediffusions seront archivées pendant au moins 90 jours après la date de présentation.
Codexis (NASDAQ: CDXS), ein führendes Unternehmen im Bereich Enzymengineering, hat seine Teilnahme an zwei bevorstehenden Gesundheitskonferenzen bekannt gegeben. Das Management wird an informellen Gesprächen teilnehmen:
1. Der Cantor Global Healthcare Conference in New York am 17. September 2024 um 11:30 Uhr ET.
2. Der Craig-Hallum Bioprocessing Conference (virtuell) am 19. September 2024 um 14:00 Uhr ET.
Ein Live-Streaming des Cantor-Gesprächs wird auf der Investor-Relations-Website des Unternehmens verfügbar sein. Eine Aufzeichnung des Craig-Hallum-Gesprächs wird innerhalb von 48 Stunden nach der Präsentation zugänglich sein. Beide Aufzeichnungen werden mindestens 90 Tage nach dem Datum der Präsentation archiviert.
- None.
- None.
REDWOOD CITY, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced that management will participate in two upcoming investor conferences.
The Cantor Global Healthcare Conference (New York, NY)
- Tuesday, September 17, 2024, at 11:30 am ET, management will participate in a fireside chat
The Craig-Hallum Bioprocessing Conference (Virtual)
- Thursday, September 19, 2024, at 2:00 pm ET, management will participate in a fireside chat
A live webcast of the Cantor fireside chat will be available in the Investor Relations section of the Company’s website, http://ir.codexis.com. A replay of the Craig-Hallum fireside chat will be available in the same location within 48 hours of the presentation. A replay of each will be archived for at least 90 days following the presentation date.
About Codexis
Codexis is a leading enzyme engineering company leveraging its proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins. Codexis enzymes solve for real-world challenges associated with small molecule pharmaceuticals manufacturing and nucleic acid synthesis. The Company is currently developing its proprietary ECO Synthesis™ manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. Codexis’ unique enzymes can drive improvements such as higher yields, reduced energy usage and waste generation, improved efficiency in manufacturing and greater sensitivity in genomic and diagnostic applications. For more information, visit https://www.codexis.com.
For More Information
Investor Contact
Carrie McKim
(336) 608-9706
ir@codexis.com
Media Contact
Lauren Musto
(650) 421-8205
media@codexis.com
FAQ
When is Codexis (CDXS) participating in the Cantor Global Healthcare Conference?
What type of event is Codexis (CDXS) participating in at the Craig-Hallum Bioprocessing Conference?
Where can I watch the Codexis (CDXS) fireside chat from the Cantor Global Healthcare Conference?
How long will the replays of Codexis (CDXS) conference presentations be available?
